nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—Somnolence—Etoposide—testicular cancer	0.000638	0.000638	CcSEcCtD
Tiagabine—Angina pectoris—Doxorubicin—testicular cancer	0.000637	0.000637	CcSEcCtD
Tiagabine—Epistaxis—Methotrexate—testicular cancer	0.000635	0.000635	CcSEcCtD
Tiagabine—Pneumonia—Epirubicin—testicular cancer	0.000634	0.000634	CcSEcCtD
Tiagabine—Nausea—Bleomycin—testicular cancer	0.000631	0.000631	CcSEcCtD
Tiagabine—Vomiting—Dactinomycin—testicular cancer	0.00063	0.00063	CcSEcCtD
Tiagabine—Bronchitis—Doxorubicin—testicular cancer	0.000629	0.000629	CcSEcCtD
Tiagabine—Rash—Dactinomycin—testicular cancer	0.000625	0.000625	CcSEcCtD
Tiagabine—Decreased appetite—Etoposide—testicular cancer	0.000623	0.000623	CcSEcCtD
Tiagabine—Diarrhoea—Ifosfamide—testicular cancer	0.000621	0.000621	CcSEcCtD
Tiagabine—Renal failure—Epirubicin—testicular cancer	0.00062	0.00062	CcSEcCtD
Tiagabine—Body temperature increased—Cisplatin—testicular cancer	0.000619	0.000619	CcSEcCtD
Tiagabine—Fatigue—Etoposide—testicular cancer	0.000618	0.000618	CcSEcCtD
Tiagabine—Neuropathy peripheral—Epirubicin—testicular cancer	0.000618	0.000618	CcSEcCtD
Tiagabine—Stomatitis—Epirubicin—testicular cancer	0.000614	0.000614	CcSEcCtD
Tiagabine—Pain—Etoposide—testicular cancer	0.000613	0.000613	CcSEcCtD
Tiagabine—Constipation—Etoposide—testicular cancer	0.000613	0.000613	CcSEcCtD
Tiagabine—Conjunctivitis—Epirubicin—testicular cancer	0.000613	0.000613	CcSEcCtD
Tiagabine—Urinary tract infection—Epirubicin—testicular cancer	0.000613	0.000613	CcSEcCtD
Tiagabine—Dysuria—Doxorubicin—testicular cancer	0.000612	0.000612	CcSEcCtD
Tiagabine—Haemoglobin—Methotrexate—testicular cancer	0.000608	0.000608	CcSEcCtD
Tiagabine—Haemorrhage—Methotrexate—testicular cancer	0.000605	0.000605	CcSEcCtD
Tiagabine—Sweating—Epirubicin—testicular cancer	0.000604	0.000604	CcSEcCtD
Tiagabine—Pollakiuria—Doxorubicin—testicular cancer	0.000604	0.000604	CcSEcCtD
Tiagabine—Haematuria—Epirubicin—testicular cancer	0.000601	0.000601	CcSEcCtD
Tiagabine—Dizziness—Ifosfamide—testicular cancer	0.0006	0.0006	CcSEcCtD
Tiagabine—Pharyngitis—Methotrexate—testicular cancer	0.0006	0.0006	CcSEcCtD
Tiagabine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000597	0.000597	CcSEcCtD
Tiagabine—Weight increased—Doxorubicin—testicular cancer	0.000595	0.000595	CcSEcCtD
Tiagabine—Epistaxis—Epirubicin—testicular cancer	0.000595	0.000595	CcSEcCtD
Tiagabine—Weight decreased—Doxorubicin—testicular cancer	0.000592	0.000592	CcSEcCtD
Tiagabine—Sinusitis—Epirubicin—testicular cancer	0.000591	0.000591	CcSEcCtD
Tiagabine—Feeling abnormal—Etoposide—testicular cancer	0.000591	0.000591	CcSEcCtD
Tiagabine—Hyperglycaemia—Doxorubicin—testicular cancer	0.00059	0.00059	CcSEcCtD
Tiagabine—Nausea—Dactinomycin—testicular cancer	0.000589	0.000589	CcSEcCtD
Tiagabine—Pneumonia—Doxorubicin—testicular cancer	0.000587	0.000587	CcSEcCtD
Tiagabine—Gastrointestinal pain—Etoposide—testicular cancer	0.000586	0.000586	CcSEcCtD
Tiagabine—Visual impairment—Methotrexate—testicular cancer	0.000583	0.000583	CcSEcCtD
Tiagabine—Vomiting—Ifosfamide—testicular cancer	0.000577	0.000577	CcSEcCtD
Tiagabine—Hypersensitivity—Cisplatin—testicular cancer	0.000577	0.000577	CcSEcCtD
Tiagabine—Renal failure—Doxorubicin—testicular cancer	0.000573	0.000573	CcSEcCtD
Tiagabine—Rash—Ifosfamide—testicular cancer	0.000573	0.000573	CcSEcCtD
Tiagabine—Dermatitis—Ifosfamide—testicular cancer	0.000572	0.000572	CcSEcCtD
Tiagabine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000572	0.000572	CcSEcCtD
Tiagabine—Urticaria—Etoposide—testicular cancer	0.00057	0.00057	CcSEcCtD
Tiagabine—Haemoglobin—Epirubicin—testicular cancer	0.000569	0.000569	CcSEcCtD
Tiagabine—Stomatitis—Doxorubicin—testicular cancer	0.000568	0.000568	CcSEcCtD
Tiagabine—Rhinitis—Epirubicin—testicular cancer	0.000567	0.000567	CcSEcCtD
Tiagabine—Abdominal pain—Etoposide—testicular cancer	0.000567	0.000567	CcSEcCtD
Tiagabine—Body temperature increased—Etoposide—testicular cancer	0.000567	0.000567	CcSEcCtD
Tiagabine—Conjunctivitis—Doxorubicin—testicular cancer	0.000567	0.000567	CcSEcCtD
Tiagabine—Urinary tract infection—Doxorubicin—testicular cancer	0.000567	0.000567	CcSEcCtD
Tiagabine—Haemorrhage—Epirubicin—testicular cancer	0.000566	0.000566	CcSEcCtD
Tiagabine—Tinnitus—Methotrexate—testicular cancer	0.000564	0.000564	CcSEcCtD
Tiagabine—Hypoaesthesia—Epirubicin—testicular cancer	0.000563	0.000563	CcSEcCtD
Tiagabine—Asthenia—Cisplatin—testicular cancer	0.000562	0.000562	CcSEcCtD
Tiagabine—Pharyngitis—Epirubicin—testicular cancer	0.000562	0.000562	CcSEcCtD
Tiagabine—Sweating—Doxorubicin—testicular cancer	0.000559	0.000559	CcSEcCtD
Tiagabine—Oedema peripheral—Epirubicin—testicular cancer	0.000557	0.000557	CcSEcCtD
Tiagabine—Haematuria—Doxorubicin—testicular cancer	0.000556	0.000556	CcSEcCtD
Tiagabine—Epistaxis—Doxorubicin—testicular cancer	0.00055	0.00055	CcSEcCtD
Tiagabine—Sinusitis—Doxorubicin—testicular cancer	0.000547	0.000547	CcSEcCtD
Tiagabine—Visual impairment—Epirubicin—testicular cancer	0.000545	0.000545	CcSEcCtD
Tiagabine—Chills—Methotrexate—testicular cancer	0.000543	0.000543	CcSEcCtD
Tiagabine—Nausea—Ifosfamide—testicular cancer	0.000539	0.000539	CcSEcCtD
Tiagabine—Diarrhoea—Cisplatin—testicular cancer	0.000536	0.000536	CcSEcCtD
Tiagabine—Alopecia—Methotrexate—testicular cancer	0.000534	0.000534	CcSEcCtD
Tiagabine—Hypersensitivity—Etoposide—testicular cancer	0.000528	0.000528	CcSEcCtD
Tiagabine—Tinnitus—Epirubicin—testicular cancer	0.000528	0.000528	CcSEcCtD
Tiagabine—Haemoglobin—Doxorubicin—testicular cancer	0.000526	0.000526	CcSEcCtD
Tiagabine—Rhinitis—Doxorubicin—testicular cancer	0.000525	0.000525	CcSEcCtD
Tiagabine—Haemorrhage—Doxorubicin—testicular cancer	0.000524	0.000524	CcSEcCtD
Tiagabine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000521	0.000521	CcSEcCtD
Tiagabine—Pharyngitis—Doxorubicin—testicular cancer	0.00052	0.00052	CcSEcCtD
Tiagabine—Oedema peripheral—Doxorubicin—testicular cancer	0.000516	0.000516	CcSEcCtD
Tiagabine—Dysgeusia—Methotrexate—testicular cancer	0.000515	0.000515	CcSEcCtD
Tiagabine—Asthenia—Etoposide—testicular cancer	0.000515	0.000515	CcSEcCtD
Tiagabine—Back pain—Methotrexate—testicular cancer	0.000509	0.000509	CcSEcCtD
Tiagabine—Chills—Epirubicin—testicular cancer	0.000508	0.000508	CcSEcCtD
Tiagabine—Pruritus—Etoposide—testicular cancer	0.000507	0.000507	CcSEcCtD
Tiagabine—Visual impairment—Doxorubicin—testicular cancer	0.000505	0.000505	CcSEcCtD
Tiagabine—Alopecia—Epirubicin—testicular cancer	0.0005	0.0005	CcSEcCtD
Tiagabine—Vomiting—Cisplatin—testicular cancer	0.000498	0.000498	CcSEcCtD
Tiagabine—Rash—Cisplatin—testicular cancer	0.000494	0.000494	CcSEcCtD
Tiagabine—Dermatitis—Cisplatin—testicular cancer	0.000493	0.000493	CcSEcCtD
Tiagabine—Diarrhoea—Etoposide—testicular cancer	0.000491	0.000491	CcSEcCtD
Tiagabine—Ill-defined disorder—Methotrexate—testicular cancer	0.000488	0.000488	CcSEcCtD
Tiagabine—Tinnitus—Doxorubicin—testicular cancer	0.000488	0.000488	CcSEcCtD
Tiagabine—Anaemia—Methotrexate—testicular cancer	0.000486	0.000486	CcSEcCtD
Tiagabine—Flatulence—Epirubicin—testicular cancer	0.000485	0.000485	CcSEcCtD
Tiagabine—Tension—Epirubicin—testicular cancer	0.000483	0.000483	CcSEcCtD
Tiagabine—Dysgeusia—Epirubicin—testicular cancer	0.000482	0.000482	CcSEcCtD
Tiagabine—Nervousness—Epirubicin—testicular cancer	0.000478	0.000478	CcSEcCtD
Tiagabine—Back pain—Epirubicin—testicular cancer	0.000476	0.000476	CcSEcCtD
Tiagabine—Malaise—Methotrexate—testicular cancer	0.000475	0.000475	CcSEcCtD
Tiagabine—Dizziness—Etoposide—testicular cancer	0.000474	0.000474	CcSEcCtD
Tiagabine—Muscle spasms—Epirubicin—testicular cancer	0.000474	0.000474	CcSEcCtD
Tiagabine—Vertigo—Methotrexate—testicular cancer	0.000473	0.000473	CcSEcCtD
Tiagabine—Leukopenia—Methotrexate—testicular cancer	0.000471	0.000471	CcSEcCtD
Tiagabine—Chills—Doxorubicin—testicular cancer	0.00047	0.00047	CcSEcCtD
Tiagabine—Nausea—Cisplatin—testicular cancer	0.000465	0.000465	CcSEcCtD
Tiagabine—Alopecia—Doxorubicin—testicular cancer	0.000463	0.000463	CcSEcCtD
Tiagabine—Cough—Methotrexate—testicular cancer	0.000459	0.000459	CcSEcCtD
Tiagabine—Ill-defined disorder—Epirubicin—testicular cancer	0.000457	0.000457	CcSEcCtD
Tiagabine—Vomiting—Etoposide—testicular cancer	0.000456	0.000456	CcSEcCtD
Tiagabine—Anaemia—Epirubicin—testicular cancer	0.000455	0.000455	CcSEcCtD
Tiagabine—Agitation—Epirubicin—testicular cancer	0.000453	0.000453	CcSEcCtD
Tiagabine—Rash—Etoposide—testicular cancer	0.000452	0.000452	CcSEcCtD
Tiagabine—Dermatitis—Etoposide—testicular cancer	0.000452	0.000452	CcSEcCtD
Tiagabine—Headache—Etoposide—testicular cancer	0.000449	0.000449	CcSEcCtD
Tiagabine—Flatulence—Doxorubicin—testicular cancer	0.000449	0.000449	CcSEcCtD
Tiagabine—Myalgia—Methotrexate—testicular cancer	0.000448	0.000448	CcSEcCtD
Tiagabine—Arthralgia—Methotrexate—testicular cancer	0.000448	0.000448	CcSEcCtD
Tiagabine—Chest pain—Methotrexate—testicular cancer	0.000448	0.000448	CcSEcCtD
Tiagabine—Tension—Doxorubicin—testicular cancer	0.000447	0.000447	CcSEcCtD
Tiagabine—Dysgeusia—Doxorubicin—testicular cancer	0.000446	0.000446	CcSEcCtD
Tiagabine—Malaise—Epirubicin—testicular cancer	0.000444	0.000444	CcSEcCtD
Tiagabine—Discomfort—Methotrexate—testicular cancer	0.000443	0.000443	CcSEcCtD
Tiagabine—Nervousness—Doxorubicin—testicular cancer	0.000443	0.000443	CcSEcCtD
Tiagabine—Vertigo—Epirubicin—testicular cancer	0.000443	0.000443	CcSEcCtD
Tiagabine—Syncope—Epirubicin—testicular cancer	0.000442	0.000442	CcSEcCtD
Tiagabine—Leukopenia—Epirubicin—testicular cancer	0.000441	0.000441	CcSEcCtD
Tiagabine—Back pain—Doxorubicin—testicular cancer	0.000441	0.000441	CcSEcCtD
Tiagabine—Muscle spasms—Doxorubicin—testicular cancer	0.000438	0.000438	CcSEcCtD
Tiagabine—Palpitations—Epirubicin—testicular cancer	0.000435	0.000435	CcSEcCtD
Tiagabine—Confusional state—Methotrexate—testicular cancer	0.000433	0.000433	CcSEcCtD
Tiagabine—Loss of consciousness—Epirubicin—testicular cancer	0.000433	0.000433	CcSEcCtD
Tiagabine—Cough—Epirubicin—testicular cancer	0.00043	0.00043	CcSEcCtD
Tiagabine—Infection—Methotrexate—testicular cancer	0.000427	0.000427	CcSEcCtD
Tiagabine—Nausea—Etoposide—testicular cancer	0.000426	0.000426	CcSEcCtD
Tiagabine—Hypertension—Epirubicin—testicular cancer	0.000425	0.000425	CcSEcCtD
Tiagabine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000423	0.000423	CcSEcCtD
Tiagabine—Anaemia—Doxorubicin—testicular cancer	0.000421	0.000421	CcSEcCtD
Tiagabine—Thrombocytopenia—Methotrexate—testicular cancer	0.000421	0.000421	CcSEcCtD
Tiagabine—Myalgia—Epirubicin—testicular cancer	0.000419	0.000419	CcSEcCtD
Tiagabine—Chest pain—Epirubicin—testicular cancer	0.000419	0.000419	CcSEcCtD
Tiagabine—Arthralgia—Epirubicin—testicular cancer	0.000419	0.000419	CcSEcCtD
Tiagabine—Agitation—Doxorubicin—testicular cancer	0.000419	0.000419	CcSEcCtD
Tiagabine—Anxiety—Epirubicin—testicular cancer	0.000418	0.000418	CcSEcCtD
Tiagabine—Hyperhidrosis—Methotrexate—testicular cancer	0.000415	0.000415	CcSEcCtD
Tiagabine—Discomfort—Epirubicin—testicular cancer	0.000414	0.000414	CcSEcCtD
Tiagabine—Malaise—Doxorubicin—testicular cancer	0.000411	0.000411	CcSEcCtD
Tiagabine—Dry mouth—Epirubicin—testicular cancer	0.00041	0.00041	CcSEcCtD
Tiagabine—Vertigo—Doxorubicin—testicular cancer	0.000409	0.000409	CcSEcCtD
Tiagabine—Anorexia—Methotrexate—testicular cancer	0.000409	0.000409	CcSEcCtD
Tiagabine—Syncope—Doxorubicin—testicular cancer	0.000409	0.000409	CcSEcCtD
Tiagabine—Leukopenia—Doxorubicin—testicular cancer	0.000408	0.000408	CcSEcCtD
Tiagabine—Confusional state—Epirubicin—testicular cancer	0.000405	0.000405	CcSEcCtD
Tiagabine—Palpitations—Doxorubicin—testicular cancer	0.000403	0.000403	CcSEcCtD
Tiagabine—Oedema—Epirubicin—testicular cancer	0.000402	0.000402	CcSEcCtD
Tiagabine—Hypotension—Methotrexate—testicular cancer	0.000401	0.000401	CcSEcCtD
Tiagabine—Loss of consciousness—Doxorubicin—testicular cancer	0.000401	0.000401	CcSEcCtD
Tiagabine—Infection—Epirubicin—testicular cancer	0.000399	0.000399	CcSEcCtD
Tiagabine—Cough—Doxorubicin—testicular cancer	0.000398	0.000398	CcSEcCtD
Tiagabine—Shock—Epirubicin—testicular cancer	0.000396	0.000396	CcSEcCtD
Tiagabine—Thrombocytopenia—Epirubicin—testicular cancer	0.000394	0.000394	CcSEcCtD
Tiagabine—Hypertension—Doxorubicin—testicular cancer	0.000393	0.000393	CcSEcCtD
Tiagabine—Tachycardia—Epirubicin—testicular cancer	0.000392	0.000392	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000391	0.000391	CcSEcCtD
Tiagabine—Hyperhidrosis—Epirubicin—testicular cancer	0.000389	0.000389	CcSEcCtD
Tiagabine—Insomnia—Methotrexate—testicular cancer	0.000389	0.000389	CcSEcCtD
Tiagabine—Chest pain—Doxorubicin—testicular cancer	0.000388	0.000388	CcSEcCtD
Tiagabine—Arthralgia—Doxorubicin—testicular cancer	0.000388	0.000388	CcSEcCtD
Tiagabine—Myalgia—Doxorubicin—testicular cancer	0.000388	0.000388	CcSEcCtD
Tiagabine—Anxiety—Doxorubicin—testicular cancer	0.000387	0.000387	CcSEcCtD
Tiagabine—Paraesthesia—Methotrexate—testicular cancer	0.000386	0.000386	CcSEcCtD
Tiagabine—Discomfort—Doxorubicin—testicular cancer	0.000383	0.000383	CcSEcCtD
Tiagabine—Anorexia—Epirubicin—testicular cancer	0.000383	0.000383	CcSEcCtD
Tiagabine—Dyspnoea—Methotrexate—testicular cancer	0.000383	0.000383	CcSEcCtD
Tiagabine—Somnolence—Methotrexate—testicular cancer	0.000382	0.000382	CcSEcCtD
Tiagabine—Dry mouth—Doxorubicin—testicular cancer	0.000379	0.000379	CcSEcCtD
Tiagabine—Dyspepsia—Methotrexate—testicular cancer	0.000378	0.000378	CcSEcCtD
Tiagabine—Hypotension—Epirubicin—testicular cancer	0.000376	0.000376	CcSEcCtD
Tiagabine—Confusional state—Doxorubicin—testicular cancer	0.000375	0.000375	CcSEcCtD
Tiagabine—Decreased appetite—Methotrexate—testicular cancer	0.000373	0.000373	CcSEcCtD
Tiagabine—Oedema—Doxorubicin—testicular cancer	0.000372	0.000372	CcSEcCtD
Tiagabine—Fatigue—Methotrexate—testicular cancer	0.00037	0.00037	CcSEcCtD
Tiagabine—Infection—Doxorubicin—testicular cancer	0.00037	0.00037	CcSEcCtD
Tiagabine—Pain—Methotrexate—testicular cancer	0.000367	0.000367	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000366	0.000366	CcSEcCtD
Tiagabine—Shock—Doxorubicin—testicular cancer	0.000366	0.000366	CcSEcCtD
Tiagabine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000364	0.000364	CcSEcCtD
Tiagabine—Insomnia—Epirubicin—testicular cancer	0.000364	0.000364	CcSEcCtD
Tiagabine—Tachycardia—Doxorubicin—testicular cancer	0.000363	0.000363	CcSEcCtD
Tiagabine—Paraesthesia—Epirubicin—testicular cancer	0.000361	0.000361	CcSEcCtD
Tiagabine—Hyperhidrosis—Doxorubicin—testicular cancer	0.00036	0.00036	CcSEcCtD
Tiagabine—Dyspnoea—Epirubicin—testicular cancer	0.000358	0.000358	CcSEcCtD
Tiagabine—Somnolence—Epirubicin—testicular cancer	0.000357	0.000357	CcSEcCtD
Tiagabine—Anorexia—Doxorubicin—testicular cancer	0.000355	0.000355	CcSEcCtD
Tiagabine—Feeling abnormal—Methotrexate—testicular cancer	0.000354	0.000354	CcSEcCtD
Tiagabine—Dyspepsia—Epirubicin—testicular cancer	0.000354	0.000354	CcSEcCtD
Tiagabine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000351	0.000351	CcSEcCtD
Tiagabine—Decreased appetite—Epirubicin—testicular cancer	0.000349	0.000349	CcSEcCtD
Tiagabine—Hypotension—Doxorubicin—testicular cancer	0.000348	0.000348	CcSEcCtD
Tiagabine—Fatigue—Epirubicin—testicular cancer	0.000347	0.000347	CcSEcCtD
Tiagabine—Pain—Epirubicin—testicular cancer	0.000344	0.000344	CcSEcCtD
Tiagabine—Constipation—Epirubicin—testicular cancer	0.000344	0.000344	CcSEcCtD
Tiagabine—Urticaria—Methotrexate—testicular cancer	0.000341	0.000341	CcSEcCtD
Tiagabine—Body temperature increased—Methotrexate—testicular cancer	0.00034	0.00034	CcSEcCtD
Tiagabine—Abdominal pain—Methotrexate—testicular cancer	0.00034	0.00034	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000339	0.000339	CcSEcCtD
Tiagabine—Insomnia—Doxorubicin—testicular cancer	0.000336	0.000336	CcSEcCtD
Tiagabine—Paraesthesia—Doxorubicin—testicular cancer	0.000334	0.000334	CcSEcCtD
Tiagabine—Dyspnoea—Doxorubicin—testicular cancer	0.000332	0.000332	CcSEcCtD
Tiagabine—Feeling abnormal—Epirubicin—testicular cancer	0.000331	0.000331	CcSEcCtD
Tiagabine—Somnolence—Doxorubicin—testicular cancer	0.000331	0.000331	CcSEcCtD
Tiagabine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000329	0.000329	CcSEcCtD
Tiagabine—Dyspepsia—Doxorubicin—testicular cancer	0.000327	0.000327	CcSEcCtD
Tiagabine—Decreased appetite—Doxorubicin—testicular cancer	0.000323	0.000323	CcSEcCtD
Tiagabine—Fatigue—Doxorubicin—testicular cancer	0.000321	0.000321	CcSEcCtD
Tiagabine—Urticaria—Epirubicin—testicular cancer	0.000319	0.000319	CcSEcCtD
Tiagabine—Constipation—Doxorubicin—testicular cancer	0.000318	0.000318	CcSEcCtD
Tiagabine—Pain—Doxorubicin—testicular cancer	0.000318	0.000318	CcSEcCtD
Tiagabine—Abdominal pain—Epirubicin—testicular cancer	0.000318	0.000318	CcSEcCtD
Tiagabine—Body temperature increased—Epirubicin—testicular cancer	0.000318	0.000318	CcSEcCtD
Tiagabine—Hypersensitivity—Methotrexate—testicular cancer	0.000316	0.000316	CcSEcCtD
Tiagabine—Asthenia—Methotrexate—testicular cancer	0.000308	0.000308	CcSEcCtD
Tiagabine—Feeling abnormal—Doxorubicin—testicular cancer	0.000307	0.000307	CcSEcCtD
Tiagabine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000304	0.000304	CcSEcCtD
Tiagabine—Pruritus—Methotrexate—testicular cancer	0.000304	0.000304	CcSEcCtD
Tiagabine—Hypersensitivity—Epirubicin—testicular cancer	0.000296	0.000296	CcSEcCtD
Tiagabine—Urticaria—Doxorubicin—testicular cancer	0.000296	0.000296	CcSEcCtD
Tiagabine—Abdominal pain—Doxorubicin—testicular cancer	0.000294	0.000294	CcSEcCtD
Tiagabine—Body temperature increased—Doxorubicin—testicular cancer	0.000294	0.000294	CcSEcCtD
Tiagabine—Diarrhoea—Methotrexate—testicular cancer	0.000294	0.000294	CcSEcCtD
Tiagabine—Asthenia—Epirubicin—testicular cancer	0.000288	0.000288	CcSEcCtD
Tiagabine—Pruritus—Epirubicin—testicular cancer	0.000284	0.000284	CcSEcCtD
Tiagabine—Dizziness—Methotrexate—testicular cancer	0.000284	0.000284	CcSEcCtD
Tiagabine—Diarrhoea—Epirubicin—testicular cancer	0.000275	0.000275	CcSEcCtD
Tiagabine—Hypersensitivity—Doxorubicin—testicular cancer	0.000274	0.000274	CcSEcCtD
Tiagabine—Vomiting—Methotrexate—testicular cancer	0.000273	0.000273	CcSEcCtD
Tiagabine—Rash—Methotrexate—testicular cancer	0.000271	0.000271	CcSEcCtD
Tiagabine—Dermatitis—Methotrexate—testicular cancer	0.000271	0.000271	CcSEcCtD
Tiagabine—Headache—Methotrexate—testicular cancer	0.000269	0.000269	CcSEcCtD
Tiagabine—Asthenia—Doxorubicin—testicular cancer	0.000267	0.000267	CcSEcCtD
Tiagabine—Dizziness—Epirubicin—testicular cancer	0.000266	0.000266	CcSEcCtD
Tiagabine—Pruritus—Doxorubicin—testicular cancer	0.000263	0.000263	CcSEcCtD
Tiagabine—Vomiting—Epirubicin—testicular cancer	0.000256	0.000256	CcSEcCtD
Tiagabine—Nausea—Methotrexate—testicular cancer	0.000255	0.000255	CcSEcCtD
Tiagabine—Diarrhoea—Doxorubicin—testicular cancer	0.000255	0.000255	CcSEcCtD
Tiagabine—Rash—Epirubicin—testicular cancer	0.000253	0.000253	CcSEcCtD
Tiagabine—Dermatitis—Epirubicin—testicular cancer	0.000253	0.000253	CcSEcCtD
Tiagabine—Headache—Epirubicin—testicular cancer	0.000252	0.000252	CcSEcCtD
Tiagabine—Dizziness—Doxorubicin—testicular cancer	0.000246	0.000246	CcSEcCtD
Tiagabine—Nausea—Epirubicin—testicular cancer	0.000239	0.000239	CcSEcCtD
Tiagabine—Vomiting—Doxorubicin—testicular cancer	0.000237	0.000237	CcSEcCtD
Tiagabine—Rash—Doxorubicin—testicular cancer	0.000235	0.000235	CcSEcCtD
Tiagabine—Dermatitis—Doxorubicin—testicular cancer	0.000234	0.000234	CcSEcCtD
Tiagabine—Headache—Doxorubicin—testicular cancer	0.000233	0.000233	CcSEcCtD
Tiagabine—Nausea—Doxorubicin—testicular cancer	0.000221	0.000221	CcSEcCtD
